India
Maurya Labs, previously known as Maurya Central Diagnostics, is the first laboratory in the Seemanchal region of India to receive NABL accreditation, distinguishing itself as a leader in pathological testing. The lab extends its high-quality healthcare services across India, Nepal, Bangladesh, and Myanmar.
Founded in 1998 by Dr. A. K. Sinha and Dr. Anurag Mohan, two of the country's esteemed pathologists with a combined experience of over 30 years, Maurya Labs has positioned itself in the analytics and healthcare industries. The founders' impressive educational backgrounds and work experience in top medical institutions cement the company's commitment to excellence.
Despite its established reputation, Maurya Labs has not reported recent investment inflows, highlighting significant opportunities for investors to aid in its growth and regional expansion. This makes Maurya Labs a unique prospect for venture capitalists aiming to influence healthcare outcomes across South Asia.
